BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28833891)

  • 1. Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns.
    Carvalho NM; Chou V; Modesto W; Margatho D; Garcia EAL; Bahamondes L
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1732-1737. PubMed ID: 28833891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
    Mejia M; McNicholas C; Madden T; Peipert JF
    Contraception; 2016 Nov; 94(5):556-560. PubMed ID: 27364099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
    Gemzell-Danielsson K; Buhling KJ; Dermout SM; Lukkari-Lax E; Montegriffo E; Apter D
    Contraception; 2016 Jun; 93(6):507-12. PubMed ID: 26872720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
    Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
    Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
    Daud S; Ewies AA
    Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
    Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
    Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use.
    Gemzell-Danielsson K; Apter D; Dermout S; Faustmann T; Rosen K; Schmelter T; Merz M; Nelson A
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():22-28. PubMed ID: 27930941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
    Fan G; Kang S; Ren M; Weisberg E; Lukkari-Lax E; Roth K; Shin S
    Contraception; 2017 Apr; 95(4):371-377. PubMed ID: 27913229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
    Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
    Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
    Darney PD; Stuart GS; Thomas MA; Cwiak C; Olariu A; Creinin MD
    Contraception; 2018 Mar; 97(3):210-214. PubMed ID: 29038072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.